← All stocks

QuidelOrtho Corp

QDEL No buying or selling
CIK 0001906324 #2532 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

19 insiders · 0 transactions
1.7×

Brian J. Blaser holds only 1.7 times base salary in stock. $1.79M of shares against $1.00M in salary for 2025.

Salary from the company's own proxy. The shares are what Brian J. Blaser last reported holding, valued at $23.59, the price Common Stock was last bought or sold at on the open market here, on 13 Feb 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
BUECHLER KENNETH F
Director
110,906
$2.62M
+27.8%
Blaser Brian J.
President and CEO
75,722
$1.79M
Busky Joseph M.
Chief Financial Officer
55,108
$1.30M
+361.8%
WIDDER KENNETH J
Director
45,073
$1.06M
+58.3%
Bujarski Robert Joseph
EVP & COO
44,810
$1.06M
+0.4%
Hodges Michelle A
Chief Legal Officer
41,605
$981.55K
+181.4%
Strobeck Matthew
Director
34,604
$816.38K
+169.4%
Michael Edward L.
Director
29,433
$694.39K
+87.4%
RHOADS ANN D
Director
23,257
$548.68K
+186.0%
McLellan Philip D.
Chief Operations Officer
22,497
$530.75K
+305.4%
POLAN MARY LAKE PH D
Director
20,442
$482.27K
+232.1%
Wilkins Joseph D Jr.
Director
18,705
$441.29K
+184.4%
Dilsaver Evelyn S
Director
17,453
$411.75K
+234.8%
Siegrist Jonathan Philip
EVP of R&D & CTO
13,419
$316.58K
Huennekens R Scott
Director
9,352
$220.63K
Chiminski John R
Director
9,352
$220.63K
Hanson Bryan Michael
EVP Global Port. Mgmt & Mkting
8,055
$190.03K
+795.0%
Bowman Ronald Lee
Chief Human Resources Officer
3,375
$79.62K
Carlyle Group Inc. entity
10% owner
0
$0.00
−100.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 1 Jun 2022